| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.005 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |